RESUS RIGHT
Working to prevent the death and disability of newborn babies who require resuscitation at birth.
Ten million babies each year require help to begin breathing.
Current tools are not always sufficient to prepare clinicians for a resuscitation.
We’re building innovative medical devices, ensuring world-class care for every infant.
The Problem
An estimated ten million newborns annually will require positive pressure ventilation to assist with breathing at birth. Each year, approximately one million newborns die of birth asphyxia, and another million newborns will survive resuscitation but with significant lifelong disabilities such as cerebral palsy.
The Solution
A device that provides quantitative feedback to the user on their resuscitation technique, allowing them to adjust, optimize and improve in real-time.
Some projects remind you why rigour matters.
Every year, millions of babies need help breathing at birth. When that happens, a clinician places a mask over the baby’s mouth and nose and manually delivers air to the lungs — a procedure performed the same way for decades. The problem is that nobody has been measuring whether it’s working. Too much air causes acute lung injury or lung collapse. Too little causes asphyxia. The margin is narrow, the consequences are permanent, and yet gas volumes and mask leakage have never been routinely monitored during one of the most critical moments in a patient’s life.
Sydney-based ResusRight was founded to change that. Their NEMO Clinical Monitor attaches to standard neonatal resuscitation equipment and gives clinicians real-time, objective feedback on the quality of ventilation they’re delivering — actual data, in the moment, when it matters most.
When ResusRight came to us, they had world-class technology and a compelling story that wasn’t being told clearly. Our job was to make the science legible, the brand trustworthy, and the materials sharp enough to open doors in Australian hospitals, and eventually in the US and European markets. We developed their visual identity, logo, brochures, and full suite of advertising materials — built to work across clinical, commercial, and investor audiences simultaneously.
That’s the work we do at Critical Design. Not chasing trends. Not overcomplicating things. Just asking the right questions, understanding what’s actually at stake, and building something that holds up under scrutiny — in print, in market, and over time.
The details that most people overlook? That’s exactly where we start.
LAUNCH
